1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Vietnam Pharmaceuticals and Healthcare Report Q2 2016

Vietnam Pharmaceuticals and Healthcare Report Q2 2016

  • April 2016
  • -
  • Business Monitor International
  • -
  • 105 pages

Includes 3 FREE quarterly updates

BMI View: Vietnam's disease profile will be increasingly attractive for prescription drugmakers as chronicconditions become more prevalent. To adequately meet this large unmet medical need, pharmaceuticalfirms will have to adapt their product portfolios to account for the low purchasing power of the populace.Equally critical will be the need to coordinate with local healthcare institutions to improve Vietnam'sdiagnosis rates, which remain impeded by its underdeveloped medical system.

Headline Expenditure Projections

- Pharmaceuticals: VND92.471trn (USD4.22bn) in 2015 to VND105.482trn (USD4.61bn) in 2016;+14.1% in local currency terms and +9.2% in US dollar terms. Forecast largely unchanged from lastquarter.

- Healthcare: VND260.29trn (USD11.9bn) in 2015 to VND286.45bn (USD12.5bn) in 2016; +10.1% inlocal currency terms and +5.4% in US dollar terms. Forecast largely unchanged from last quarter.

Table Of Contents

Vietnam Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Vietnam 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Vietnam 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Vietnam 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Vietnam 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Vietnam 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Vietnam 2012-2020) 21
Patented Drug Market Forecast 22
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Vietnam 2012-2020) 23
Generic Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Vietnam 2012-2020) 25
OTC Medicine Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Vietnam 2012-2020) 28
Pharmaceutical Trade Forecast 29
Table: Pharmaceutical Trade Data And Forecasts (Vietnam 2014-2020) 31
Table: Pharmaceutical Trade Data And Forecasts local currency (Vietnam 2014-2020) 31
Pharmaceuticals and Healthcare Risk/Reward Index 32
Asia Pacific Risk/Reward Index 32
Vietnam Risk/Reward Index 38
Rewards 38
Risks 38
Regulatory Review 40
Intellectual Property Issues 42
Pricing Regime 46
Reimbursement Regime 51
Market Overview 54
Healthcare Sector 55
Table: Healthcare Resources (Vietnam 2010-2015) 58
Table: Healthcare Personnel (Vietnam 2010-2015) 58
Table: Healthcare Activity (Vietnam 2010-2015) 59
Research and Development 64
Clinical Trials 68
Competitive Landscape 74
Research-Based Industry 74
Table: Multinational Market Activity 78
Pharmaceutical Distribution 79
Pharmaceutical Retail Sector 79
Table: Key Aspects Of Good Pharmacy Practice In Developing Countries 81
Company Profile 82
DHG Pharmaceutical 82
GlaxoSmithKline 84
Sanofi 86
Traphaco Pharmaceutical 89
Vietnam Pharmaceutical Corporation (Vinapharm) 91
Demographic Forecast 94
Table: Population Headline Indicators (Vietnam 1990-2025) 95
Table: Key Population Ratios (Vietnam 1990-2025) 95
Table: Urban/Rural Population and Life Expectancy (Vietnam 1990-2025) 96
Table: Population By Age Group (Vietnam 1990-2025) 96
Table: Population By Age Group % (Vietnam 1990-2025) 97
Glossary 99
Methodology 101
Pharmaceutical Expenditure Forecast Model 101
Healthcare Expenditure Forecast Model 101
Notes On Methodology 102
Risk/Reward Index Methodology 103
Index Overview 104
Table: Pharmaceutical Risk/Reward Index Indicators 104
Indicator Weightings 105

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.